Given the key role of GLUT2 in the liver, it explains some of the abnormalities observed in glucose metabolism in FBS patients (fasting hypoglycemia, postprandial hyperglycemia, and glycogen storage). The gene discussed is SLC2A2; the disease is Hyperglycemia.